常染色体显性多囊肾病终末期肾病患者特征分析
本研究回顾性分析Mayo Clinic的ADPKD合并ESKD患者,测量身高调整总肾脏体积(HtTKV)并计算Mayo影像分类,确定基因型。发现ESKD时HtTKV随年龄增长而缩小,每十年缩小12.3%(P<0.01),女性显著(17.8%,P<0.01),男性不显著(6.9%,P=0.06)。不同发病年龄组特征不同,年轻患者以囊性生长为主,老年患者血管疾病等因素更重要。
要点
- ADPKD患者ESKD时HtTKV随年龄增长而缩小,女性更显著。
- 年轻ESKD患者以囊性生长为主,老年患者血管疾病等因素更重要。
- 不同发病年龄组在性别、影像分类、基因型和血管疾病分布上存在差异。
核心结论
- ADPKD患者ESKD时HtTKV随年龄增长而缩小,尤其女性;年轻患者以囊性生长为主,老年患者衰老相关因素包括血管疾病可能重要。
研究设计与样本
- 回顾性横断面研究,纳入Mayo Clinic的ADPKD合并ESKD且有腹部CT或MRI的患者。
主要发现
- ESKD时HtTKV随年龄每十年缩小12.3%(P<0.01),女性缩小17.8%(P<0.01),男性缩小6.9%(P=0.06)。
- ESKD发病年龄<47、47-61、>61岁组特征不同:男性比例减少女性增加,MIC从1D/1E变为1B/1C,完全外显PKD1突变从95%降至42%,大血管疾病从8%升至40%。
- 女性患者中大血管疾病与更小的肾脏相关。
临床怎么用
- 评估ADPKD患者ESKD风险时需考虑年龄和性别对肾脏体积的影响。
- 年轻ESKD患者应关注囊性生长,老年患者需评估血管疾病等衰老相关因素。
局限性
- 回顾性横断面研究,样本来自单中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cystic expansion damaging the parenchyma is thought to lead to end-stage kidney disease (ESKD) in autosomal dominant polycystic kidney disease (ADPKD). Here we characterized genotypic and phenotypic attributes of ADPKD at time of ESKD. METHODS: This is a retrospective cross-sectional study of patients with ADPKD with ESKD evaluated at Mayo Clinic with available abdominal computed tomography (CT) or magnetic resonance imaging (MRI). Kidney volumes were measured (total kidney volume adjusted for height [HtTKV]), Mayo Image Class (MIC) calculated, ADPKD genotype determined, and clinical and laboratory features obtained from medical records. RESULTS: Differences in HtTKV at ESKD were associated with patient age and sex; older patients and women had smaller HtTKV at ESKD. HtTKV at ESKD was observed to be 12.3% smaller with each decade of age (P < 0.01); but significant only in women (17.8%, P < 0.01; men 6.9%, P = 0.06). Patients with onset of ESKD at <47, 47-61, or >61 years had different characteristics, with a shift from youngest to oldest in male to female enrichment, MIC from 1D/1E to 1B/1C, likely fully penetrant PKD1 mutations from 95% to 42%, and presence of macrovascular disease from 8% to 40%. Macrovascular disease was associated with smaller kidneys in female patients. CONCLUSION: HtTKV at ESKD was smaller with advancing age in patients with ADPKD, particularly in women. These novel findings provide insight into possible underlying mechanisms leading to ESKD, which differ between younger and older individuals. Cystic growth is the predominant mechanism in younger patients with ESKD, whereas aging-related factors, including vascular disease, becomes potentially important as patients age.
引用
- Shukoor SS, Vaughan LE, Edwards ME, et al. Characteristics of Patients with End-Stage Kidney Disease in ADPKD. Kidney Int Rep. 2020. PMID: 33732990. doi:10.1016/j.ekir.2020.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。